Scout | NCI R61: Early-Stage Tech Development for Cancer Research Tools and Biospecimen Quality

This opportunity is no longer accepting applications.

grant

NCI R61: Early-Stage Tech Development for Cancer Research Tools and Biospecimen Quality

The National Cancer Institute is inviting R61 grant applications to develop and test new technologies for molecular or cellular cancer characterization, or for improved biospecimen handling and quality control. Projects should be early-stage proof-of-concept/pilot studies focused on cancer-relevant use cases, including technical feasibility of assays, platforms, instruments, or tools. Using ex…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: National Cancer Institute

Dates

Release Date: June 3, 2026

Expiration Date: November 11, 2026

Keywords

cancer research

technology development

biospecimen quality

molecular analysis

assay development

pilot study

imaging tools

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers